Key result
The novel mnemonic 'THROMBINS2' was developed to replace the outdated 'MONA' to help clinicians recall all elements of contemporary acute coronary syndrome management.
Answers are grounded in this paper and cite their sources.
The novel mnemonic 'THROMBINS2' updates the outdated 'MONA' to better reflect contemporary, evidence-based therapies for acute coronary syndrome.
Acute coronary syndrome (ACS) remains a major burden on morbidity and mortality in the United States. Medical professionals and students often use the mnemonic 'MONA' (morphine, oxygen, nitroglycerin and aspirin) to recall treatments for ACS; however, this list of therapies is outdated. We provide a historical perspective on 'MONA,' attempt to uncover its origin in the medical literature, and demonstrate the myriad changes that have occurred over the last 50 years of ACS management. We have developed a novel mnemonic, 'THROMBINS2' (thienopyridines, heparin/enoxaparin, renin-angiotensin system blockers, oxygen, morphine, beta blocker, intervention, nitroglycerin, statin/salicylate) to help bedside clinicians recall all the elements of contemporary ACS management. We demonstrate the mortality benefit for each component of contemporary ACS management, correlating the continued improvement with historical data on mortality after myocardial infarction. We encourage providers to utilize this mnemonic to explore options and guide treatments in ACS patients.
No takes yet. Share an insight, caveat, or question.
Kline et al. (2015) conducted a review in Acute coronary syndrome. THROMBINS2 mnemonic vs. MONA mnemonic was evaluated. The novel mnemonic 'THROMBINS2' was developed to replace the outdated 'MONA' to help clinicians recall all elements of contemporary acute coronary syndrome management.
Synapse has enriched 10 related papers. Consider them for comparative context: